ARTICLE | Company News
Sigmoid Pharma, Pharmascience deal
November 3, 2014 8:00 AM UTC
Sigmoid granted Pharmascience's Pendopharm division exclusive rights to commercialize CyCol in Canada. Pendopharm invested EUR5 million ($6.4 million) in Sigmoid, which will also receive an undisclos...